Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.4, replacing v3.5.3, indicating a new build of the page rendering. No changes to study content are reflected in this update.
    Difference
    0.1%
    Check dated 2026-05-16T09:08:19.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page indicates an updated site revision number (from v3.5.2 to v3.5.3). This reflects a versioning update of the page itself rather than a substantive change to the trial information.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; the previous v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:31:15.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T09:39:32.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T05:09:42.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    The update includes a minor site-version revision (Revision: v3.4.2) and removal of a government-operating-status notice; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T16:29:28.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.